High-risk APL

Children with acute promyelocytic leukemia are sorted into risk groups at diagnosis, and the presenting white cell count is the basis for the split. The PDQ summary notes that children present with high white cell counts more often than adults, and that patients in the high-risk group receive an anthracycline with induction therapy. Because the group changes induction treatment, the count at diagnosis matters.